We are delighted to announce that Asthma Research and Practice has launched a new allergy section that is now open to submissions! The section is edited by Dr Olympia Tsilochristou MD PhD, Consultant Allergist and considers all aspects of allergy with a particular focus on links between asthma and allergic rhinitis, drug hypersensitivity reactions, and food allergy as well as on allergen immunotherapy and biologicals for asthma/allergic rhinitis. If you would like more information on the section’s aims and scopes or on the suitability of your manuscript for the journal, please do reach out using the Contact button at the bottom of the page.
New Allergy Section
Featured article: Biological therapy for severe asthma
Around 5–10% of the total asthmatic population suffer from severe or uncontrolled asthma, which is associated with increased mortality and hospitalization, increased health care burden and worse quality of life. In the last few years, new drugs have been launched and several asthma phenotypes according to definite biomarkers have been identified. In particular, therapy with biologics has revolutionized the management and the treatment of severe asthma, showing high therapeutic efficacy associated with significant clinical benefits. The aim of this article was to review the biologic therapies currently available for the treatment of severe asthma, in order to help physicians to choose the most suitable biologic agent for their asthmatic patients.
Aims and scope
Asthma Research and Practice publishes cutting edge basic, clinical and translational research in addition to hot topic reviews and debate articles relevant to asthma and related disorders (such as rhinitis, COPD overlapping syndrome, sinusitis). The journal has a specialized section which focusses on pediatric asthma research.
Asthma Research and Practice aims to serve as an international platform for the dissemination of research of interest to pulmonologists, allergologists, primary care physicians and family doctors, ENTs and other health care providers interested in asthma, its mechanisms and comorbidities.
Annual Journal Metrics
20 days to first decision for all manuscripts
45 days to first decision for reviewed manuscripts only
94 days from submission to acceptance
13 days from acceptance to publication
109,568 Downloads (2021)
108 Altmetric mentions